Key result
Second-stage bidirectional cavopulmonary anastomosis for HLHS is linked to an absolute ~61% lower early mortality.
Why the study?
Outcomes after stage I palliation for hypoplastic left heart syndrome and risk factors for mortality at subsequent palliative procedures were not well characterized at this institution.
Does a second-stage bidirectional cavopulmonary anastomosis improve survival compared to a nonfenestrated Fontan operation in patients with hypoplastic left heart syndrome?
Cohort (n=72)
No
Does a second-stage bidirectional cavopulmonary anastomosis improve survival compared to a nonfenestrated Fontan operation in patients with hypoplastic left heart syndrome?
A second-stage bidirectional cavopulmonary anastomosis for hypoplastic left heart syndrome significantly reduces mortality compared to a primary nonfenestrated Fontan, allowing for a safer third-stage fenestrated Fontan operation.
Answers are grounded in this paper and cite their sources.
Supports bidirectional cavopulmonary shunt as stage II palliation in HLHS; leaves open optimal selection and long-term Fontan timing.
OBJECTIVES: The aim of this study was to perform a retrospective analysis of an institutional experience with a consecutive series of patients with post-stage I palliation for hypoplastic left heart syndrome (HLHS). BACKGROUND: In a recent review of 212 consecutive patients who underwent stage I operations for HLHS at our institution between 1983 and 1993, we identified risk factors related to stage I mortality. We sought to examine the outcome for these patients at subsequent palliative procedures. METHODS: All patients who underwent stage I reconstruction between January 1983 and June 1993 and also underwent subsequent palliation at our institution were included. Seventy patients underwent palliative procedures and two underwent heart transplantation. Patient-specific factors and features of the stage II operation were analyzed for impact on stage II mortality and actuarial survival. RESULTS: The only independent risk factor for stage II mortality was the performance of a nonfenestrated Fontan operation (p < 0.001). There were nine in-hospital deaths (69%) in the 13 patients undergoing the nonfenestrated Fontan procedure at stage II. Fifty patients underwent intermediate superior vena cava to pulmonary artery anastomosis at stage II, with 4 (8%) early deaths. Pulmonary artery augmentation was performed in 19 patients (38%) at stage II, without increased operative risk. Hypoplastic left heart syndrome anatomic subtype did not influence stage II mortality. The modified fenestrated Fontan procedure has been performed as a third stage in 32 patients whose median age was 28.7 months, with one early death at a median follow-up of 24.5 months. CONCLUSIONS: A second-stage bidirectional cavopulmonary anastomosis for HLHS reduces second-stage mortality and improves intermediate survival. The modified fenestrated Fontan operation may then be performed as a final palliative stage with low operative risk.
No takes yet. Share an insight, caveat, or question.
Forbess et al. (1997) conducted a cohort in Hypoplastic left heart syndrome (HLHS) (n=72). Second-stage bidirectional cavopulmonary anastomosis vs. Nonfenestrated Fontan operation was evaluated on Stage II mortality (p=<0.001). Second-stage bidirectional cavopulmonary anastomosis for HLHS resulted in lower early mortality compared to a nonfenestrated Fontan operation.
Synapse has enriched 10 related papers. Consider them for comparative context: